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Background: Airway inflammation and asthma have been linked to oxidative stress and the melastatin-related
transient receptor potential cation channel, member 2 (TRPM2), which can be activated by reactive oxygen species
(ROS), has emerged as a potential therapeutic target for inflammatory diseases.
Objective: Using TRPM2 deficient (TRPM2-/-) mice, we investigated whether the TRPM2 ion channel, which
mediates calcium (Ca2+) influx and lysosomal Ca2+ release, plays a role in the pathophysiology of severe allergic
asthma in mouse.
Methods: Severe allergic asthma was initiated in wild type (WT) and TRPM2-/- mice by repeated sensitization with
ovalbumin (OVA)/aluminum hydroxide on Days 0, 7 and 14, followed by intranasal challenge on Days 21, 22 and 23.
Mice were investigated for the presence of airway responsiveness, airway inflammation, production of allergen-
specific antibodies, cytokine response and lung pathology.
Results: The absence of TRPM2 channels has no obvious effect on major etiologic markers of severe allergic
asthma in this mouse model. Neither airway resistance nor mucus production are affected in TRPM2-/- mice. TRPM2
channel ablation also does not alter airway inflammation or immunocyte infiltration and does not affect antibody
response or cytokine levels.
Conclusions: TRPM2 is not required for airway inflammation in OVA-induced severe allergic asthma in mice.
Accordingly, TRPM2 might not be a suitable therapeutic target for airway inflammation caused by allergens in
humans.
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Asthma is a chronic airway inflammation characterized by
intense eosinophil, mast cell, and lymphocyte infiltration,
mucus hyper-production, and airway hyper-responsiveness
[1]. Asthma symptoms develop when allergens activate
antigen-specific helper T-lymphocytes (Th) to produce Th-
2 cytokines, such as interleukin (IL)-4, IL-5, and IL13 [1].
Activated phagocytic cells (neutrophils, eosinophils, mono-
cytes and macrophages) also play a role in the pathophysi-
ology of airway inflammation due their release of large* Correspondence: rpenner@hawaii.edu
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distribution, and reproduction in any mediumamounts of reactive oxygen species (ROS), lipid mediators,
and cytokines [2,3]. Airway cells and tissues are also
exposed to oxidative stress elicited by environmental pol-
lutants (ozone, cigarette smoke, and dust), infections, in-
flammatory reactions or decreased levels of antioxidants
that lead to enhanced levels of ROS [3,4]. It has been
shown that ROS can damage DNA, lipids, proteins, and
carbohydrates leading to impaired cellular functions and
enhanced inflammatory reactions [3]. Consequently, it has
been suggested that ROS play a role in airway disorders
such as adult respiratory, distress syndrome (ARDS), cystic
fibrosis, idiopathic fibrosis, chronic obstructive pulmonary
diseases (COPD), and asthma [3,5].
The mammalian super family of transient receptor po-
tential (TRP) cation channels can be subdivided into sixCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ical), TRPV (vanilloid), TRPM (melastatin), TRPA
(ankyrin), TRPP (polycystin) and TRPML (mucolipin)
[6,7]. TRP channels express in a broad range of cell
types including sensory nerves, lung fibroblast, epithelial
cells and immune cells [6,7]. Relevant to the context of
asthma, TRPA1 channels have been implicated in pain
and inflammatory responses in the airways in mice [8].
In addition, the TRPM2 channel has been implicated in
stress-related inflammatory and neurodegenerative con-
ditions [9-11]. However, the relevance of TRPM2 in se-
vere asthma pathophysiology has not yet been explored.
TRPM2 is a non-selective calcium (Ca2+) influx and
lysosomal Ca2+ release channel expressed in neutrophils
[9,12], monocytes [9], Jurkat T cells [13], INS-1 cells [14]
and mouse bone marrow derived-dendritic cells (BMDC)
[15]. TRMP2 is co-activated by intracellular adenosine di-
phosphate ribose (ADPR) and Ca2+, downstream of ROS
and chemokine signaling pathways [11,15-17]. TRPM2 ac-
tivation by ADPR is further facilitated by the presence of
nicotinic acid adenine dinucleotide phosphate (NAADP),
cyclic ADPR (cADPR), and hydrogen peroxide (H2O2)
[18-21], whereas adenosine monophosphate (AMP) and
permeating protons (pH) negatively regulate TRPM2
activation [21-24].
TRPM2-deficient mice are more resistant to chronic
experimental colitis due to defective chemokine (C-X-C
motif ) ligand 2 (CXCL2) production by monocytes and
reduced neutrophil infiltration [9]. Yet, a recent publica-
tion has suggested no role for TRPM2 channel in
chronic obstructive pulmonary disease [25]. Intriguingly,
cADPR induces Ca2+ release in airway smooth muscle
(ASM) [26,27] and acetylcholine (ACh) and endothelin-1
(ET-1) are considered to regulate airway caliber through
cADPR-mediated Ca2+ release in these cells [28]. More-
over, mice that lack CD38, an ectoenzyme that generates
free ADPR through the hydrolysis of nicotinamide aden-
ine dinucleotide (NAD+) and its cADPR glycohydrolase
activity, exhibit altered airway responsiveness to
methacholine [28,29].
In the present study, we assessed the role of TRPM2
channels in airway inflammation by using an experimental
OVA-induced severe asthma model. We found that airway
responsiveness, airway inflammation, production of allergen-
specific antibodies, and cytokine response were unaffected in
TRPM2-/- mice when compared to OVA-sensitized and chal-
lenged WT mice. Our findings suggest that in this experi-




C57BL/6trpm2+/+(wild type; WT) and C57BL/6 trpm2-/-
(knock out; TRPM2-/-) mice were bred and housedunder pathogen free conditions. TRPM2-/-mice were
generated as previously described [9]. All mice were ge-
notyped by PCR before the experiments to confirm dis-
ruption of trpm2-/- gene. Mice were 8-12 weeks old at
the time of the experiments. All protocols involving ro-
dents were reviewed and approved by The Institutional
Laboratory Animal Care and Use Committee (IACUC)
at The University of Hawaii and The University of Cali-
fornia, San Francisco.
Allergen sensitization and challenge of mice
Sensitization and challenge of mice were performed as
previously described [30]. Briefly, TRPM2-/- mice and
WT littermate were sensitized intraperitoneally with
50 μg ovalbumin (OVA; grade V; Sigma-Aldrich) plus
1 mg Alum (Sigma-Aldrich) in 200 μl 0.9% sodium
chloride (saline; Hospira) on Days 0, 7, and 14. On Days
21, 22 and 23, mice were anesthetized with isoflurane
(Hospira) and challenged with 100 μg OVA in 50 μl sa-
line by nasal administration. Control groups were
treated identically except OVA was missing in the solu-
tions. Mice were euthanized and studied on Day 24.
Measurement of airway hyper-responsiveness
Airway resistance in response to intravenously adminis-
tered acetylcholine was measured using a flexiVent system
(SCIREQ, Montreal, Canada) as previously described [30].
Mice were anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg) and acepromazine (2-3 mg/kg); para-
lyzed with pancuronium (0.1 mg/kg intraperitoneally),
intubated with a 20G cannula and mechanically ventilated
at a frequency of 150 breaths per minute and 2 cmH2O
positive end-expiratory. Lung resistance was measured at
baseline and in response to increasing intravenous doses
of acetylcholine (0, 0.1, 0.3, 1, 3 and 9.6 μg/g body weight)
using the linear single compartment model.
Bronchoalveolar lavage fluid (BAL) leukocytes count
Lungs from sacrificed mice were flushed once with 1 ml
PBS/1% fetal calf serum (FCS) to obtain bronchoalveolar
lavage (BAL) fluid. The total number of cells was deter-
mined by a hemocytometer. A maximum of 2 × 105 cells
were centrifuged on a microscope slide and stained with
Diff-Quick (Polyscience). Differential cell counts were
made at 3400 magnification, and at least 100 cells were
counted per slide.
Histology and immunohistochemistry
For histologic analysis of goblet cell hyperplasia, tissue
samples were fixed in 4% phosphate-buffered formalin,
embedded in paraffin, cut into 5-7 μm sections and
stained with periodic acid-Schiff (PAS) reagent (Sigma-
Aldrich) following manufacturer instructions. To evalu-
ate inflammatory infiltration, tissue sections were stained
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200x magnification by examining 40 consecutive fields
of the peribronchiolar, perivascular, and alveolar areas.
Mast cells were counted at 20x magnification in lung
sections stained with toluidine blue.
Detection of serum IgE antibodies
Blood samples were collected using the heart puncture
method and serum was separated by centrifugation for
15 minutes at 6000 g. OVA-specific IgE antibodies were
measured in a serum dilution series by endpoint titration
enzyme-linked immunosorbent assay (ELISA). Briefly,
plates were coated with 1 mg/ml OVA and alkaline
phosphatase-conjugated anti-mouse isotype specific anti-
bodies (Southern Biotechnology) and 4-nitrophenyl
phosphate (Sigma-Aldrich) were used for detection.
Absorbance was measured at 405 nm with 492 nm as a
reference wavelength.
Cytokine levels
The concentration of interleukin IL-5, IL-6, IL-10, IL-13
and transforming growth factor beta 1 (TGFB1) in the
BAL fluid of five independent OVA and saline treated
WT and TRPM2-/- mice were measured using the spe-
cific Single Analyte ELISArray™ Kit (Qiagen) following
manufacturer instructions. Samples were analyzed at
450 nm using a Benchmark plus microplate reader spec-
trophotometer (BioRad).
Statistical analysis
Data are reported as mean ± SEM. Significance testing
was performed by Student’s paired t-test for significant
differences between two groups and ANOVA to test sig-
nificant differences among the groups of mice. A value
of p < 0.05 was considered to be statistically significant.
Results
Airway resistance and mucus production are not affected
in TRPM2-/- mice
Given that airway inflammation and asthma have been
linked to oxidative stress [2], we investigated whether
TRPM2, a Ca2+-permeable ion channel involved in ROS
signaling, contributes to pathophysiology. For this, we
analyzed the inflammatory allergic reaction of WT and
TRPM2-/- mice in an OVA-induced severe asthma
model. Airway reactivity was measured in WT and
TRPM2-/- mice following OVA or saline challenge. As il-
lustrated in Figure 1B, we observed an increase in airway
resistance in both OVA-challenged WT and TRPM2-/-
mice when assessing responses to increasing doses of
acetylcholine (filled symbols) compared to saline-
challenged WT and TRPM2-/- mice (open symbols), in-
dicating the development of airway hyper-reactivity
(AHR). Thus, the airway resistance in OVA-treated WTand TRPM2-/- mice was significantly increased with no
significant differences between the mouse strains.
Hyperplasia of mucus-producing goblet cells in the
lung is also a characteristic of allergic asthma [1,31].
Therefore, we investigated the hyperplasia of goblet cells
by histologic examination of PAS-stained lungs from
OVA- and saline-sensitized and challenged WT and
TRPM2-/- mice. We observed that OVA-sensitized WT
and TRPM2-/- mice showed similar severity of goblet cell
hyperplasia (Figure 1B, bottom panels; see magnified
inset), while the saline group showed no signs of in-
creased hyperplasia (Figure 1B, top panel). Hence, ab-
sence of TRPM2 seems to have no significant influence
on airway resistance and mucus production.TRPM2 channel ablation does not alter allergic airway
inflammation
It has been shown that TRPM2 channels control neutro-
phil infiltration in a mouse model of colitis by regulating
CXCL2 chemokine production in monocytes [9]. BMDC
from TRPM2-/- mice also exhibit compromised chemo-
taxis towards CXCL12 and CCL19 chemokines [15]. To
further evaluate whether TRPM2 contributes to airway
inflammation and severe asthma, we examined whether
the recruitment of inflammatory cells into the lungs was
affected in the absence of TRPM2 channels. To assess
the inflammatory response, we scored the histological
changes in the lung parenchyma of OVA- and saline-
challenged WT and TRPM2-/- mice. As illustrated in
Figure 2A, OVA induced significant inflammatory cell
infiltration into the lung parenchyma in both WT and
TRPM2-/-mice (filled bars) compared to mice that re-
ceived saline only (open bars); however, no difference
was observed between the two mouse strains. In
addition, the total number of cells in the BAL fluid of
OVA-challenged WT mice was significantly higher than
in the control group challenged with saline, however,
this did not differ from the total number of cells recov-
ered in BAL fluid from OVA-challenged TRPM2-/- mice
(Figure 2B). The differential cell count revealed that eosin-
ophils were the main cell type in BAL fluid (Figure 2C), as
is characteristically observed in allergic airway inflamma-
tion, yet no significant difference was found between the
mice strains. Cell counts of macrophages (Figure 2D), lym-
phocytes (Figure 2E), and neutrophils (Figure 2F) were not
different in the BAL fluid from OVA-challenged WT and
TRPM2-/- mice (Figure 2D). In contrast, mast cell counts
in the lung tissue of OVA-challenged mice were not in-
creased in either group and WT and TRPM2-/- remained
similar (Figure 2E). Together, these data indicate that the
TRPM2 channel does not regulate the bronchoalveolar
inflammatory cell infiltration in an OVA-induced severe
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Figure 1 Airway resistance and mucus production are not affected in TRPM2-/- mice. A) General priming and challenge scheme for the
experimental allergic model used in all investigations (see Methods for details). B) Airway resistance to increasing concentrations of intravenously
administered acetylcholine in WT (black symbols) and TRPM2-/- (red symbols) mice challenged with OVA and saline. Values represent means ± SEM
(n = 10) from 2 experiments with 5 mice per group. ACh concentrations of 3 μM or higher produced significantly higher resistance in OVA-treated mice
compared to saline-treated, but no significance differences were observed between WT and TRPM2-/- mice. C) PAS staining of lungs from WT (left panels)
or TRPM2-/- mice (right panels) challenged with saline (top panels) or OVA (bottom panels). Images are representative of 10 mice per group. Relevant areas
of normal and inflamed tissue with mucus-producing goblet cells are marked by a square and shown as enlarged insets in each graph (aw = airway).
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Figure 2 TRPM2 channel ablation does not alter allergic airway inflammation. A) Ranked inflammation scores for alveolar, peribronchiolar and
perivascular regions of the lung, prepared by staining with hematoxylin and eosin, from OVA and saline-challenged WT and TRPM2-/- mice. B-F) BAL cells
were collected, identified and enumerated microscopically using Diff-Quick stained preparations. Total cell numbers (B) and numbers of eosinophils (C),
macrophages (D), lymphocytes (E), and neutrophils (F) in the BAL fluid, and mast cells (G) in toluidine blue-stained lung tissue of WT and TRPM2-/- mice
challenged with saline or OVA. Except for mast cells, cell numbers were significantly increased by OVA challenge in both WT and TRPM2-/- mice, but no
significant difference was seen between WT and TRPM2-/- mice. Data are shown as means ± SEM from 10 mice per group (* indicates p < 0.05).
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cytokine levels
We next investigated whether antibody responses to aller-
gens were affected in TRPM2-/- mice. For this, we deter-
mined serum levels of OVA-specific IgE antibodies in WT
and TRPM2-/- mice treated with OVA or saline. Figure 3
shows a significant increase in OVA-specific IgE antibodies
in OVA-challenged WT and TRPM2-/- mice compared to
saline treated mice with no apparent difference between
the two mice strains after repeated exposure to OVA. Since
TRPM2 can also regulate cytokine secretion [9], we exam-
ined whether Th2-type cytokines were affected by
disrupted TRPM2 channels. We measured levels of IL-5,
IL-6, IL-10, IL-13 and TGFB1 in the BAL fluid of OVA-
and saline-treated WT and TRPM2-/- mice. The results
revealed that OVA challenge evoked significant and com-
parable levels of IL-6, IL-10, TGFB1 and IL-13 cytokines in
WTand TRPM2-/- mice (Figure 4). IL-5 levels were not de-
tectable in mice treated with saline or OVA (data not
shown), possibly due to detection limits of the experimen-
tal kit used. In summary, these data indicate that TRPM2
channels are not involved in the pathophysiology of OVA-
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Figure 3 Allergen-specific antibody responses of WT and
TRPM2-/- mice are similar. Serum OVA-specific IgE antibodies in WT
and TRPM2-/- mice following saline or OVA treatment and measured
by endpoint ELISA. OVA-IgE antibodies were significantly increased in
both OVA-treated WT and TRPM2-/- mice, but no significant difference
was seen between WT and TRPM2-/- mice. Data represent mean values
± SEM from 10 mice per group (* indicates p < 0.05).Discussion
Allergen-induced airway inflammation is an eosinophilic
inflammation and type 2 T and B lymphocytes-driven re-
sponse [1]. In this study, we investigated the role of
TRPM2 channels in the pathophysiology of severe
asthma by using TRPM2-deficient mice in a model of
OVA-induced inflammatory airway disease. Our data in-
dicate that TRPM2 channels are not required for acute
airway inflammation to occur. Deletion of TRPM2 did
not affect airway resistance (Figure 1B), mucus produc-
tion (Figure 1C), inflammatory cell infiltration (Figure 2),
allergen-induced production of IgE (Figure 3), and cyto-
kine production (Figure 4) following allergen treatment.
This is somewhat surprising in light of previous studies
that used the dextran sulphate sodium (DSS)-induced
chronic experimental colitis mouse model [9] and the
lipopolysaccharide (LPS)-induced lung inflammation
mouse model [32]. In the colitis model, the TRPM2
channel controls CXCL2 production in monocytes and
consequently affects neutrophil infiltration, and in the
lung inflammation model, TRPM2 plays a protective role
by preventing ROS production in neutrophils. DSS in-
duces inflammatory bowel disease-like colitis in mice by
causing toxicity in colonic epithelial cells of the basal
crypts [33]. Moreover, the inflammatory response is me-
diated by monocyte-dependent chemokine production in
response to locally generated ROS [9]. Interestingly, LPS
may regulate lung inflammation via Toll-like receptor 4
(TLR4) signaling in alveolar macrophages [34], whereas
allergen-induced airway inflammation is driven by type 2
T lymphocytes and cytokines [1]. In contrast to the
above studies, a recent study of chronic obstructive pul-
monary disease (COPD) showed no role for TRPM2 in
airway inflammation in mice exposed to ozone, LPS or
tobacco smoke [25]. The CD8+ cell is the accepted cru-
cial lymphocyte subtype in COPD. Therefore, TRPM2
appears to be preferentially involved in chronic inflam-
matory responses with a strong phagocytic cell compo-
nent and might not have a prominent role in acute
inflammatory processes. It also suggests that redundant
mechanisms, including other ion channels, might com-
pensate for the absence of TRPM2 channels during
certain inflammatory processes. Other chronic inflam-
matory models should be used to address this hypoth-
esis, including models of chronic allergen exposure or
using alternative allergens such as dust mite and cock-
roach extracts.
The TRPM2 channel is expressed in the plasma mem-
brane of neutrophils and monocytes/macrophages [9]
and in lysosomes of BMDC [15] and controls their
chemotaxis or cytokine production by regulating intra-
cellular calcium concentration upon cell activation.
TRPM2-deficient neutrophils exhibit defective in vitro
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Figure 4 Cytokine response is not modified in the absence of TRPM2 channels. Levels of IL-6 (A), IL-13 (B), IL-10 (C), and TGFβ1 (D) in the
BAL fluid of OVA- and saline-treated WT and TRPM2-/- mice (bld = below levels of detection). Significant elevations in the level of cytokines were
detected following OVA treatment in WT and TRPM2-/- mice compared to saline control group (ctrl), but no significant difference was found
between mouse strains. Values represent pooled data ± SEM from 5 mice per group (* indicates p < 0.05).
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tide chain produced by some bacteria [9], although
CXCL2-mediated responses remained unaffected. TRPM2-/-
neutrophils are also defective in ROS production [32]. In
our model of allergen induced-chronic inflammation, dele-
tion of TRPM2 expression did not affect IL-6, IL-10, IL-13
and TGFβ1 production (Figure 4) or inflammatory cell infil-
tration into the airway (Figure 2).
A central mediator of asthma is the IgE antibody,
which is produced by sensitized allergen-specific B cells
[1]. Allergens increase IgE levels in the serum of suscep-
tible subjects subsequent to stimulation [1]. IgE anti-
bodies then bind to the high-affinity IgE receptor, Fc
epsilon receptor I (FcεRI), present in mast cells, eosino-
phils, and basophils, thereby sensitizing these cells to
allergen exposure [1]. IgE-FcεRI complexes trigger de-
granulation of cytoplasmic vesicles containing histamine
and de novo formation of eicosanoids and ROS in mast
cells, eosinophils, and basophils, resulting in smooth
muscle contraction [1]. Our data indicate that TRPM2
channels have no direct effect on allergen-induced pro-
duction of IgE (Figure 3).
Airway caliber regulation by ACh and ET-1 occurs
through a yet to be elucidated mechanism involvingcADPR-mediated Ca2+ release in ASM cells [28]. It is
known that cADPR activates ryanodine receptors [35]
and can facilitate TRPM2 activation [36]. In addition,
airway responsiveness to methacholine is altered in the
absence of CD38, an ectoenzyme that generates free
ADPR and cADPR from NAD+ [28,29]. In our study, we
observed no difference in airway resistance between
TRPM2-deficient mice and WT mice challenged with
OVA, suggesting that ACh does not require TRPM2 ac-
tivity to regulate airway caliber. Interestingly, another
TRP channel, TRPA-1, appears relevant to allergen-
induced asthma models, since TRPA-1 knockout mice
were shown to be more resistant to airway inflammation
and hyperactivity than WT mice [8].
Conclusions
In conclusion, although TRPM2 appears to be involved
in certain inflammatory responses that are mediated by
monocyte-dependent chemokine production in response
to ROS, this inflammatory mechanism may not domin-
ate the mechanisms engaged in the OVA-mediated se-
vere airway inflammation model. Hence, this model
might not be suitable to test for TRPM2 as a therapeutic
target for allergen-induced airway inflammation or the
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mediated inflammation. Nevertheless, further investiga-
tions using a less severe asthma model are needed to fully
address the role of TRPM2 in lung inflammation.
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